David Fineberg

Title: **David Fineberg: Innovating Therapeutic Delivery Systems**

Introduction

David Fineberg is an accomplished inventor based in Raleigh, NC, who has made significant contributions to the field of therapeutic delivery devices. With a total of two patents, Fineberg's work focuses on advancing methods for delivering critical thrombolytic agents, which are essential in medical treatments.

Latest Patents

Fineberg’s latest patents revolve around the development of therapeutic delivery devices, systems, and methods specifically designed for the delivery of thrombolytic agents, including plasmin. These innovations not only facilitate the effective delivery of therapeutics but also enhance the process by allowing for the occlusion of a vessel or graft, either distal or proximal to the treatment zone. Moreover, these systems are designed to trap emboli, which significantly addresses complications often faced in medical treatments involving thrombolytic therapies.

Career Highlights

Throughout his career, Fineberg has worked with prominent companies in the healthcare sector, including Grifols Therapeutics Inc. and Grifols, S.A. His professional journey has been marked by a commitment to innovation in therapeutic solutions, particularly in the area of vascular treatment.

Collaborations

David Fineberg has collaborated with notable individuals in the industry, such as Dean Chamberlain and Valery Novokhatny. These partnerships have furthered his ability to innovate and develop cutting-edge solutions in therapeutic delivery technologies.

Conclusion

In summary, David Fineberg stands out as a notable inventor whose patents in therapeutic delivery systems reflect his dedication to improving medical treatments. His innovative contributions are set to make a lasting impact on the healthcare industry, providing more effective solutions for patients requiring thrombolytic therapies.